Literature DB >> 33499355

Return of the Neurotropic Enteroviruses: Co-Opting Cellular Pathways for Infection.

Christine E Peters1, Jan E Carette1.   

Abstract

Enteroviruses are among the most common human infectious agents. While infections are often mild, the severe neuropathogenesis associated with recent outbreaks of emerging non-polio enteroviruses, such as EV-A71 and EV-D68, highlights their continuing threat to public health. In recent years, our understanding of how non-polio enteroviruses co-opt cellular pathways has greatly increased, revealing intricate host-virus relationships. In this review, we focus on newly identified mechanisms by which enteroviruses hijack the cellular machinery to promote their replication and spread, and address their potential for the development of host-directed therapeutics. Specifically, we discuss newly identified cellular receptors and their contribution to neurotropism and spread, host factors required for viral entry and replication, and recent insights into lipid acquisition and replication organelle biogenesis. The comprehensive knowledge of common cellular pathways required by enteroviruses could expose vulnerabilities amenable for host-directed therapeutics against a broad spectrum of enteroviruses. Since this will likely include newly arising strains, it will better prepare us for future epidemics. Moreover, identifying host proteins specific to neurovirulent strains may allow us to better understand factors contributing to the neurotropism of these viruses.

Entities:  

Keywords:  CRISPR and haploid screens; EV-A71; EV-D68; antivirals; enteroviruses; host-directed therapeutics; neuropathogenesis; picornaviruses; viral tissue tropism; virus–host interactions

Mesh:

Substances:

Year:  2021        PMID: 33499355      PMCID: PMC7911124          DOI: 10.3390/v13020166

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  128 in total

Review 1.  Enterovirus Infections of the Central Nervous System in Children: An Update.

Authors:  Henriette Rudolph; Horst Schroten; Tobias Tenenbaum
Journal:  Pediatr Infect Dis J       Date:  2016-05       Impact factor: 2.129

2.  Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307.

Authors:  Lucian Albulescu; Joëlle Bigay; Bishyajit Biswas; Marion Weber-Boyvat; Cristina M Dorobantu; Leen Delang; Hilde M van der Schaar; Young-Sik Jung; Johan Neyts; Vesa M Olkkonen; Frank J M van Kuppeveld; Jeroen R P M Strating
Journal:  Antiviral Res       Date:  2017-01-11       Impact factor: 5.970

3.  A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P exchange by the ER-Golgi tether OSBP.

Authors:  Bruno Mesmin; Joëlle Bigay; Joachim Moser von Filseck; Sandra Lacas-Gervais; Guillaume Drin; Bruno Antonny
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

4.  Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP.

Authors:  Lucian Albulescu; Jeroen R P M Strating; Hendrik Jan Thibaut; Lonneke van der Linden; Matthew D Shair; Johan Neyts; Frank J M van Kuppeveld
Journal:  Antiviral Res       Date:  2015-03-06       Impact factor: 5.970

5.  Microbiota-independent antiviral effects of antibiotics on poliovirus and coxsackievirus.

Authors:  Mikal A Woods Acevedo; Julie K Pfeiffer
Journal:  Virology       Date:  2020-04-08       Impact factor: 3.616

6.  A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIβ.

Authors:  Hilde M van der Schaar; Pieter Leyssen; Hendrik J Thibaut; Armando de Palma; Lonneke van der Linden; Kjerstin H W Lanke; Céline Lacroix; Erik Verbeken; Katja Conrath; Angus M Macleod; Dale R Mitchell; Nicholas J Palmer; Hervé van de Poël; Martin Andrews; Johan Neyts; Frank J M van Kuppeveld
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

7.  Oxysterol-binding protein family I is the target of minor enviroxime-like compounds.

Authors:  Minetaro Arita; Hirotatsu Kojima; Tetsuo Nagano; Takayoshi Okabe; Takaji Wakita; Hiroyuki Shimizu
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

8.  The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model.

Authors:  Chikako Kataoka; Tadaki Suzuki; Osamu Kotani; Naoko Iwata-Yoshikawa; Noriyo Nagata; Yasushi Ami; Takaji Wakita; Yorihiro Nishimura; Hiroyuki Shimizu
Journal:  PLoS Pathog       Date:  2015-07-16       Impact factor: 6.823

9.  Hijacking of multiple phospholipid biosynthetic pathways and induction of membrane biogenesis by a picornaviral 3CD protein.

Authors:  Sravani Banerjee; David Aponte-Diaz; Calvin Yeager; Suresh D Sharma; Gang Ning; Hyung S Oh; Qingxia Han; Masato Umeda; Yuji Hara; Robert Y L Wang; Craig E Cameron
Journal:  PLoS Pathog       Date:  2018-05-21       Impact factor: 6.823

10.  Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71.

Authors:  Yi-Wen Lin; Shu-Ling Yu; Hsiao-Yun Shao; Hsiang-Yin Lin; Chia-Chyi Liu; Kuang-Nan Hsiao; Ebenezer Chitra; Yueh-Liang Tsou; Hsuen-Wen Chang; Charles Sia; Pele Chong; Yen-Hung Chow
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more
  3 in total

1.  Obesity Exacerbates Coxsackievirus Infection via Lipid-Induced Mitochondrial Reactive Oxygen Species Generation.

Authors:  Seong-Ryeol Kim; Jae-Hyoung Song; Jae-Hee Ahn; Myeong Seon Jeong; Yoon Mee Yang; Jaewon Cho; Jae-Hyeon Jeong; Younggil Cha; Kil-Nam Kim; Hong Pyo Kim; Sun-Young Chang; Hyun-Jeong Ko
Journal:  Immune Netw       Date:  2022-04-11       Impact factor: 5.851

2.  High throughput sequencing of whole transcriptome and construct of ceRNA regulatory network in RD cells infected with enterovirus D68.

Authors:  Junzhuo Si; Xia Tang; Lei Xu; Huichao Fu; Huayi Li; Yonglin He; Jiajia Bao; Jialing Tang; Anlong Li; Nan Lu; Chun Yang
Journal:  Virol J       Date:  2021-11-07       Impact factor: 4.099

Review 3.  Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus.

Authors:  Cinzia Auriti; Domenico Umberto De Rose; Alessandra Santisi; Ludovica Martini; Fiammetta Piersigilli; Iliana Bersani; Maria Paola Ronchetti; Leonardo Caforio
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-06-10       Impact factor: 6.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.